InsidersTradesSigma
Track the DXVX stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, DXVX has published 149 insider filings. Market capitalisation: €244.6bn. The latest transaction was reported on 16 July 2026 (Purchase). Among the most active insiders: 강현웅. Every trade is accessible without an account.
144
Insider Decl.
n/a
Thresholds
€1m
61 ops.
Buy Volume
n/a
20 ops.
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,796 of 28,803 companies
13.4
score / 100
Value17
Quality10
FCF yld-8.1%
Earn yld-12%
EV/EBITDA·
ROE-9.6%
Gross mgn11%
Net mgn-99%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 July 2026
Declarations149 total
Other
Other
Other
Other
Other
25 of 149 declarations
About DXVX
DXVX is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market.